Open company graph database — free web & API
Login

General Incorporated Association Japan Blood Product Organization

一般社団法人日本血液製剤機構
Ticker
—
Listed market
—
Country
Japan
Employees (consolidated)
1,262
Related companies
14
§01

Basic information

BASIC
Head office
15th floor, Tamachi Station Tower N, 1-1-3 Shibaura, Minato-ku, Tokyo 108-0023
Chief executive
Eigo Nakanishi
Capital
Employees (non-consolidated)
Employees (consolidated)
1,262 people
Start date
2012-10-01
End date
§02

Websites

1 DOMAINS
§03

Business

7
Supply of products that meet customer needsEnhancement and strengthening of production systemsBuilding a stable business foundationContribution to the Asia regionManagement of people and organizationConsideration for the global environmentCoexistence with local communities
§04

Related companies

14 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Mitsubishi Well Pharma Co., Ltd.
Group
Mitsubishi Chemical Corporation
Group
Japanese Red Cross Society
Group
International plasma fractionation association
Group
ウェルファイド株式会社
Group
Japan Blood Products Association
Group
三菱東京製薬株式会社
Group
吉富製薬株式会社
Group
東京田辺製薬株式会社
Group
株式会社ベネシス
Group
株式会社ミドリ十字
Group
株式会社三菱ケミカルホールディングス
Group
株式会社日本ブラッド・バンク
Group
Tanabe Mitsubishi Pharma Corporation
Group
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

37 EVENTS

Establishment of Japan Blood Bank Co., Ltd. (Headquarters Osaka)Sources

Japan Red Cross Blood BankSources

Tokyo office begins blood donation operationsSources

First plasma fractionation product in JapanSources

Release of Globulin-B Bank (3ml, 10ml)Sources

Completion of plasma fractionation facility at Tsushima plantSources

Completion of plasma fractionation building at Japan Red Cross Central Blood BankSources

Japan Blood Bank Co., Ltd. changes its name to Midori Jūji Co., Ltd.Sources

Start of operations at Yodogawa plantSources

Commencement of plasma fractionation product manufacturing at Yodogawa plantSources

Start of plasma fractionation product manufacturing due to the establishment of Japan Red Cross Central Blood CenterSources

Completion of Osadano plant, predecessor of Kyoto plantSources

Completion of Osadano plant buildings 1–3Sources

Japanese Red Cross Society Plasma Fractionation Center established, Chitose plant completedSources

Coagulation building completedSources

Osadanoh factory research building completedSources

Transferred alcohol fractionation process from Yodogawa plant to Osadanoh factorySources

Osadanoh factory Building 4 completedSources

Research building completedSources

Yoshitomi Pharmaceutical Co., Ltd. and Midori Juji Co., Ltd. merged, business commenced as Yoshitomi Pharmaceutical Co., Ltd.Sources

Mitsubishi Chemical Co., Ltd. and Tokyo Tanabe Pharmaceutical Co., Ltd. merged, spun off the pharmaceutical business, and established Mitsubishi Tokyo Pharmaceutical Co., Ltd.Sources

Transferred part of the raw fractionation process of Tojima plant to Osadanoh factory and closed Tojima plantSources

Yoshitomi Pharmaceutical Co., Ltd. changed its name to Wellfied Co., Ltd.Sources

Mitsubishi Tokyo Pharmaceutical Co., Ltd. and Wellfied Co., Ltd. merged, changing name to Mitsubishi Wellfama Co., Ltd.Sources

Osadanoh factory Building 5 completedSources

Split off the biologics manufacturing division from Mitsubishi Wellfama Co., Ltd. and established Benesis Co., Ltd.Sources

Fractionation building (3) completedSources

Integration of Yodogawa plant and Osadanoh factory completed, Yodogawa plant closedSources

Mitsubishi Chemical Holdings Co., Ltd. establishedSources

Osadanoh factory Building 6 completedSources

Osadanoh factory renamed to Kyoto factorySources

Tanabe Pharmaceutical Co., Ltd. and Mitsubishi Wellfama Co., Ltd. merged, changing name to Tanabe Mitsubishi Pharmaceutical Co., Ltd.Sources

Benesis Co., Ltd. becomes a subsidiary of Tanabe Mitsubishi Pharmaceutical Co., Ltd.Sources

Founded on June 1, 2012 (Heisei 24)Sources

General Incorporated Association Japan Blood Product OrganizationSources

Business commencementSources

Business commenced on October 1 of that yearSources

§07

News

0 ARTICLES

There is no news.

§08

Public records

GOV
National Tax Agency basic information6010405010777
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
一般社団法人日本血液製剤機構
Trade name (kana)
ニッポンケツエキセイザイキコウ
Name in English
Corporation type
399
Address
〒108-0023 東京都港区芝浦3丁目1番1号田町ステーションタワーN15階
Postal code
1080023
Prefecture code
13
City code
103
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2021-01-08
Change date
2020-12-28
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
12
Correction type
1
Trade name image ID
Address image ID
Sequence number
2056096
METI gBizINFO6010405010777
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
6010405010777
Trade name
一般社団法人日本血液製剤機構
Trade name (kana)
ニッポンケツエキセイザイキコウ
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
東京都港区芝浦3丁目1番1号田町ステーションタワーN15階
Postal code
1080023
Prefecture
東京都
Prefecture code
13
City or district
港区
City code
103
Street address
芝浦3丁目1番1号田町ステーションタワーN15階
Organisation type
399
Processing type
12
Correction type
1
Status
Representative
Capital
Employees
1206
Employees (male)
912
Employees (female)
294
Business summary
医薬品製造販売
Website URL
https://www.jbpo.or.jp/csr/theme5.html
Year founded
Business category
E:製造業
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2021-01-08
Key information
6010405010777
§09

Sources & updates

SOURCES
↑